Effects of Family Sodium Watcher Program on Outcomes in Heart Failure Patient-Family Caregiver Dyads (FAMSWAP)
Heart Failure

About this trial
This is an interventional supportive care trial for Heart Failure focused on measuring Diet, low-sodium, caregivers
Eligibility Criteria
Inclusion Criteria:
Eligible patients will:
- have diagnosis of chronic HF with either preserved or reduced ejection fraction
- have a dedicated primary family caregiver
- be able to speak and write English
Eligible caregivers will:
- be a primary caregiver identified by the patient
- the spouse, committed partner, or family member living with the HF patient
- be able to speak and understand English
- have no obvious major clinical cognitive impairment that would impair ability to give informed consent
- have no major co-morbidities (i.e. HF, cancer, renal/liver failure, or uncontrolled diabetes as determined by self-report).
Exclusion Criteria:
Patients will be excluded if they have:
- major clinical cognitive impairment (i.e., dementia, Alzheimer disease, and severe stroke)
- a co-existing terminal illness (e.g., cancer)
- a referral for heart transplantation
- a dietary prescription that prevents following a 2-3 gram sodium diet (e.g., clinician does not support use of a SRD).
- no dedicated caregivers
Sites / Locations
- University of Kentucky HealthCare
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Family SWaP intervention
Usual Care
an educational-behavioral intervention consisting of 6 weekly education sessions (45 minutes) followed by 5 bi-weekly sessions (15-20 minutes) that will be held at the dyad's preferred time delivered to their homes using a video conferencing program through a mini iPad.
The usual care group will receive their routine medical and nursing care for heart failure that consists of a recommendation to follow a sodium restricted diet without explicit skills training to do so.